Science Pool

Download this fact sheet to learn more about our regulatory ADMET services including:

• Full support of development projects to fulfill and anticipate regulatory requirements
• Accelerated development process with a full vision through all drug development phases up to filing
• Dynamic team of expert scientists capable of handling projects of any complexity in regulated environment
• Full integration with in-house bioanalytical and safety assessment groups
• Tailored studies and programs based on specific client needs

DOWNLOAD

Learn more about how our INDiGO-Select services help in profiling and selecting your optimal clinical development candidate with:

• Enhanced quality profile, speed of delivery, and probability of success of clinical candidates
• Early identification of developability gaps and liabilities in selection process, enabling thorough
  de-risking of your candidate with flexible advanced lead optimization approaches
• Managed by skilled discovery scientists and complemented by experienced drug development
  experts in CMC and preclinical development all under one roof

DOWNLOAD

Learn more about our clinical services platform including:

• Fully integrated drug development services supporting preclinical and clinical needs,
  up to regulatory approval and commercial phases
• Clinical supply suitable from First in Human to Phase III, fully GMP-compliant and
  with capacity to handle active ingredients classified up to OEB5 (OEL>0.5 µg/m³)
• Additional capabilities such as API, formulation development, sample management, PK and statistical analyses, and metabolism

DOWNLOAD

Date: 16 June 2022

Location: Novartis Institutes for BioMedical Research, Cambridge, MA

Attendees: Ralf Geiben Lynn, Sravani Adusumalli & Janice Lau

Presenting: Sravani Adusumalli - Development of a High-Throughput and Efficient Automated Workflow to Determine Blood to Plasma Ratio

Learn more about NE-ADME (New Era of ADME & Beyond)

Date: 10-12 May 2022

Location: Vertex Pharmaceuticals, Boston, MA

Attendees: Ralf Geiben Lynn & Chris Strock 

Presenting: Identifying Seizures with MEA: Complementary Human and Rat Neuronal models enhance predictivity & High throughout RNA-seq profiling of 3D liver organoids to predict Drug Induced Liver Injury (DILI). - Chris Strock

Learn more about Applied Pharmaceutical Toxicology 2022

Date: 22nd - 23rd March 2022

Venue: Radisson Blu | Berlin, Germany

Olivier Casamitjana, SVP, Global Sample Management Head at Evotec and his team will present a poster about "Acoustic Tube Technology Used in Sample Management".

We hope to see you there!

LEARN MORE

Date: 7th - 8th April 2022

Venue: CentraleSupélec Campus | Paris-Saclay

Christelle Dagoneau, SVP Business Development at Just - Evotec Biologics, will give a presentation on “How AI, ML and Continuous Manufacturing Technologies Can Drive Flexible cGMP Manufacturing of Kilograms to Metric Tons of Biologics Therapeutics: The J.POD® Facility Example” | 7th April at 17:30

LEARN MORE

Date: 28 April 2022

Location: The Fielder Centre, Hatfield UK

Attendee: Oksana Nikolayenko 

Learn more about 33rd Medicinal Chemistry in Eastern England

Date: 3-4 May 2022 

Location: Javits Center - New York - USA

Attendee: Ralf Geiben-Lynn

Presenting: Scalable in silico Simulation for Human Total Body Exposure Prediction using in vitro Transdermal and Respiratory Tract Permeability Assays Tract 1A02 -Ralf Geiben-Lynn

Read more about NYSCC Suppliers' Day 2022 - New York Society of Cosmetic Chemists

Date: March 9th, 2022

Venue: Alderley Park Conference Centre

Attendees:  

• Pia Thommes, VP Anti-Infectives at Evotec and Virology TA leader will be giving a conference welcome and chairing a panel on the State of the AMR Nation (at 8:55 and 9:30 respectively)
  
  
• Sebastien Coyne, Group leader, In vitro Biology at Evotec will be giving a talk titled “The Vivo Mimetic Media Platform for Discovering and Characterizing Novel Mode of Action Antibiotics” (at 15:40)

LEARN MORE ABOUT BioInfect